Native Human Apolipoprotein C-III

• Cat.No.: APOC3-361H
• Product Overview: Native human APOC3expressed by Human Plasma is a 8.76 kDa protein.

Specification

• Cat. No.: APOC3-361H
• Description: APOC3inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of APOC3result in higher fatty acid uptake from plasma triglycerides into adiposetissue. Thus, APOC3 is a potential target for treatment of obesity andinsulin resistance. The normal plasma concentration of APOC3 is 8-15 mg per100 ml. Prepared from fresh, non-frozen plasma shown to be non reactive forHbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDAapproved tests. >95 percent pure by SDS-PAGE.
• Source: Human Plasma
• Species: Human
• Form: Liquid in 0.01MAmmonium Bicarbonate; pH 7.4.
• Molecular Weight: 8.76 kDa
• Concentration: 1.0 mg/ml
• Purity: >95 percent pure by SDS-PAGE
• Storage: When stored at -80°Cproduct is stable for 3 years from date of delivery. Avoid repeatedfreeze-thaw cycles.
• OfficialSymbol: APOC3
• Tag: Non

Gene Information

• Gene Name: APOC3 apolipoprotein C-III [ Homosapiens ]
• Synonyms: APOC3; apolipoproteinC-III; HALP2; APOCIII; MGC150353; apolipoproteinC-III; apo-CIII; apoC-III; apolipoprotein C3; OTTHUMP00000043270;OTTHUMP00000069353
• Gene ID: 345
• mRNA Refseq: NM_000040
• Protein Refseq: NP_000031
• MIM: 107720
• UniProt ID: P02656
• Chromosome Location: 11q23.1-q23.2
• Pathway: Chylomicron-mediatedlipid transport; HDL-mediated lipid transport; Lipid digestion; Lipoproteinmetabolism; Metabolism of lipids and lipoproteins; PPAR signaling pathway;Statin Pathway
• Function: cholesterol binding;enzyme regulator activity; high-density lipoprotein particle receptorbinding; lipase inhibitor activity; phospholipid binding